BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12410443)

  • 1. [Deficits in quality care by physicians].
    Zönnchen B
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2346. PubMed ID: 12410443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Using routine data for quality of care assessments: a critical review, taking quality indicators for the "National Disease Management Guideline for Chronic Heart Failure" as an example].
    Laux G; Nothacker M; Weinbrenner S; Störk S; Blozik E; Peters-Klimm F; Szecsenyi J; Scherer M
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(1):21-6. PubMed ID: 21382601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the quality of care for patients with coronary heart disease: the design and baseline results of the hastening the effective application of research through technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Parker DG; Cohen SJ
    Am J Manag Care; 2002 Dec; 8(12):1069-78. PubMed ID: 12500883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
    Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.
    Joynt KE; Gattis WA; Hasselblad V; Fuzaylov SY; Serebruany VL; Gurbel PA; Gaulden LH; Felker GM; Whellan DJ; O'Connor CM
    Am J Cardiol; 2004 Mar; 93(6):783-5. PubMed ID: 15019895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improved heart failure care with the Q failure project. Results of a quality-assurance projects with a bonus program].
    Olsson BS; Kullberg M; Landgren M
    Lakartidningen; 2010 Sep 15-21; 107(37):2154-7. PubMed ID: 21043154
    [No Abstract]   [Full Text] [Related]  

  • 7. [It is necessary to modify or to optimize the preoperative treatment?].
    Piriou V
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1104-7. PubMed ID: 17997076
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient adherence: the next frontier in quality improvement.
    Heidenreich PA
    Am J Med; 2004 Jul; 117(2):130-2. PubMed ID: 15234651
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project.
    Goff DC; Massing MW; Bertoni AG; Davis J; Ambrosius WT; McArdle J; Duren-Winfield V; Sueta CA; Croft JB
    Am Heart J; 2005 Oct; 150(4):717-24. PubMed ID: 16209973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina.
    Bertoni AG; Duren-Winfield V; Ambrosius WT; McArdle J; Sueta CA; Massing MW; Peacock S; Davis J; Croft JB; Goff DC
    Am J Cardiol; 2004 Mar; 93(6):714-8. PubMed ID: 15019875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL; Ahmed A
    J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of patients with heart failure: are internists as good as cardiologists?
    Bonarjee VV; Dickstein K
    Eur Heart J; 2001 Apr; 22(7):530-1. PubMed ID: 11259139
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 16. [Questionable group concept. How interchangeable are so-called analog drug preparations?].
    Wehling M
    MMW Fortschr Med; 2002 Nov; 144(46):56-8. PubMed ID: 12534084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions to manage coronary heart disease.
    Parkinson D
    Nurs Times; 2003 Jul 8-14; 99(27):48-9. PubMed ID: 12882058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing and managing asymptomatic left ventricular dysfunction after myocardial infarction.
    Albert NM; Lewis C
    Crit Care Nurse; 2008 Apr; 28(2):20-37; quiz 38. PubMed ID: 18378726
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines in heart failure. Too little adherence by the family practitioner?].
    MMW Fortschr Med; 2001 Sep; 143(38):14. PubMed ID: 11601084
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the management of heart failure: differences in guideline perspectives.
    Jessup M; Brozena SC
    Cardiol Clin; 2007 Nov; 25(4):497-506; v. PubMed ID: 18063155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.